These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3535393)

  • 1. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Kvetny J; Frandsen NE; Johnsen T; Dieperinck H; Mogensen E
    Acta Med Scand; 1986; 220(2):189-91. PubMed ID: 3535393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe Graves' ophthalmopathy with cyclosporin A.
    Utech C; Wulle KG; Bieler EU; Pfannenstiel P; Panitz N; Kiefer H
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):493-8. PubMed ID: 3911714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Witte A; Landgraf R; Markl A; Boergen KP; Hasenfratz G; Pickardt CR
    Klin Wochenschr; 1985 Oct; 63(19):1000-4. PubMed ID: 3840854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin improves Graves' ophthalmopathy.
    Weetman AP; McGregor AM; Ludgate M; Beck L; Mills PV; Lazarus JH; Hall R
    Lancet; 1983 Aug; 2(8348):486-9. PubMed ID: 6136647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant Graves' ophthalmopathy with cyclosporin-A--a case report.
    Bakó G; Forizs E; Herczeg L; Kolozsvari L; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):574-6. PubMed ID: 3441606
    [No Abstract]   [Full Text] [Related]  

  • 6. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
    N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent effect of cyclosporin-A on the TSH-receptor antibody synthesis in patients with Graves' disease.
    Balázs C; Kiss E; Farid NR
    Acta Med Hung; 1988; 45(1):43-52. PubMed ID: 3412862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment.
    Howlett TA; Lawton NF; Fells P; Besser GM
    Lancet; 1984 Nov; 2(8411):1101. PubMed ID: 6150174
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.
    Kahaly G; Schrezenmeir J; Krause U; Schweikert B; Meuer S; Muller W; Dennebaum R; Beyer J
    Eur J Clin Invest; 1986 Oct; 16(5):415-22. PubMed ID: 3100309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of severe endocrine ophthalmopathy with cyclosporin A].
    Bakó G; Fórizs E; Herczeg L; Kolozsvári L; Leövey A
    Orv Hetil; 1987 Aug; 128(35):1843-4. PubMed ID: 3627788
    [No Abstract]   [Full Text] [Related]  

  • 13. Ciclosporine and Graves' ophthalmopathy.
    Gayno JP; Strauch G
    Horm Res; 1987; 26(1-4):190-7. PubMed ID: 3596468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy].
    Yang H; Wu Z; Huang X; Xie C; Yang P
    Yan Ke Xue Bao; 1999 Jun; 15(2):78-80. PubMed ID: 12579704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic evaluation of Graves' ophthalmopathy.
    Bahn RS; Garrity JA; Bartley GB; Gorman CA
    Endocrinol Metab Clin North Am; 1988 Sep; 17(3):527-45. PubMed ID: 3065079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy.
    Nagayama Y; Izumi M; Kiriyama T; Yokoyama N; Morita S; Kakezono F; Ohtakara S; Morimoto I; Okamoto S; Nagataki S
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):513-8. PubMed ID: 3321820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.